|
| Over 500 products: |
| anti-bcl-2 (human), mAb (Bcl-2/100) | ANC-357-020 | Ancell | Summary Details |
|
| anti-bcl-2 (human), mAb (Bcl-2/100) (Biotin) | ANC-357-030 | Ancell | Summary Details |
|
| anti-bcl-2 (human), mAb (Bcl-2/100) (FITC) | ANC-357-040 | Ancell | Summary Details |
|
| anti-bcl-2 (human), mAb (Bcl-2/100) (R-PE) | ANC-357-050 | Ancell | Summary Details |
|
| anti-CD10 (human), mAb (SN5c) | ANC-157-020 | Ancell | Summary Details |
|
| anti-CD10 (human), mAb (SN5c) (Biotin) | ANC-157-030 | Ancell | Summary Details |
|
| anti-CD10 (human), mAb (SN5c) (FITC) | ANC-157-040 | Ancell | Summary Details |
|
| anti-CD10 (human), mAb (SN5c) (preservative free) | ANC-157-820 | Ancell | Summary Details |
|
| anti-CD10 (human), mAb (SN5c) (R-PE) | ANC-157-050 | Ancell | Summary Details |
|
| anti-CD100 (human), mAb (133-1C6) | ANC-321-020 | Ancell | Summary Details |
|
| anti-CD100 (human), mAb (133-1C6) (Biotin) | ANC-321-030 | Ancell | Summary Details |
|
| anti-CD100 (human), mAb (133-1C6) (FITC) | ANC-321-040 | Ancell | Summary Details |
|
| anti-CD100 (human), mAb (133-1C6) (preservative free) | ANC-321-820 | Ancell | Summary Details |
|
| anti-CD104 (human), mAb (UMA9) | ANC-325-020 | Ancell | Summary Details |
|
| anti-CD104 (human), mAb (UMA9) (Biotin) | ANC-325-030 | Ancell | Summary Details |
|
| anti-CD104 (human), mAb (UMA9) (FITC) | ANC-325-040 | Ancell | Summary Details |
|
| anti-CD104 (human), mAb (UMA9) (preservative free) | ANC-325-820 | Ancell | Summary Details |
|
| anti-CD104 (human), mAb (UMA9) (R-PE) | ANC-325-050 | Ancell | Summary Details |
|
| anti-CD105 (human), mAb (SN6) | ANC-326-020 | Ancell | Summary Details |
|
| anti-CD105 (human), mAb (SN6) (APC) | ANC-326-060 | Ancell | Summary Details |
|
| anti-CD105 (human), mAb (SN6) (Biotin) | ANC-326-030 | Ancell | Summary Details |
|
| anti-CD105 (human), mAb (SN6) (FITC) | ANC-326-040 | Ancell | Summary Details |
|
| anti-CD105 (human), mAb (SN6) (preservative free) | ANC-326-820 | Ancell | Summary Details |
|
| anti-CD105 (human), mAb (SN6) (R-PE) | ANC-326-050 | Ancell | Summary Details |
|
| anti-CD106 (human), mAb (1.G11B1) | ANC-327-020 | Ancell | Summary Details |
|
| anti-CD106 (human), mAb (1.G11B1) (Biotin) | ANC-327-030 | Ancell | Summary Details |
|
| anti-CD106 (human), mAb (1.G11B1) (FITC) | ANC-327-040 | Ancell | Summary Details |
|
| anti-CD106 (human), mAb (1.G11B1) (preservative free) | ANC-327-820 | Ancell | Summary Details |
|
| anti-CD106 (human), mAb (1.G11B1) (R-PE) | ANC-327-050 | Ancell | Summary Details |
|
| anti-CD117 (human), mAb (57A5) | ANC-338-020 | Ancell | Summary Details |
|
| anti-CD117 (human), mAb (57A5) (APC) | ANC-338-060 | Ancell | Summary Details |
|
| anti-CD117 (human), mAb (57A5) (Biotin) | ANC-338-030 | Ancell | Summary Details |
|
| anti-CD117 (human), mAb (57A5) (preservative free) | ANC-338-820 | Ancell | Summary Details |
|
| anti-CD117 (human), mAb (57A5) (R-PE) | ANC-338-050 | Ancell | Summary Details |
|
| anti-CD11a (human), mAb (38) | ANC-158-020 | Ancell | Summary Details |
|
| anti-CD11a (human), mAb (38) (Biotin) | ANC-158-030 | Ancell | Summary Details |
|
| anti-CD11a (human), mAb (38) (FITC) | ANC-158-040 | Ancell | Summary Details |
|
| anti-CD11a (human), mAb (38) (preservative free) | ANC-158-820 | Ancell | Summary Details |
|
| anti-CD11a (human), mAb (38) (R-PE) | ANC-158-050 | Ancell | Summary Details |
|
| anti-CD11b (human), mAb (ICRF44) | ANC-159-020 | Ancell | Summary Details |
|
| anti-CD11b (human), mAb (ICRF44) (APC) | ANC-159-060 | Ancell | Summary Details |
|
| anti-CD11b (human), mAb (ICRF44) (Biotin) | ANC-159-030 | Ancell | Summary Details |
|
| anti-CD11b (human), mAb (ICRF44) (FITC) | ANC-159-040 | Ancell | Summary Details |
|
| anti-CD11b (human), mAb (ICRF44) (preservative free) | ANC-159-820 | Ancell | Summary Details |
|
| anti-CD11b (human), mAb (ICRF44) (R-PE) | ANC-159-050 | Ancell | Summary Details |
|
| anti-CD11c (human), mAb (3.9) | ANC-160-020 | Ancell | Summary Details |
|
| anti-CD11c (human), mAb (3.9) (APC) | ANC-160-060 | Ancell | Summary Details |
|
| anti-CD11c (human), mAb (3.9) (Biotin) | ANC-160-030 | Ancell | Summary Details |
|
| anti-CD11c (human), mAb (3.9) (FITC) | ANC-160-040 | Ancell | Summary Details |
|
| anti-CD11c (human), mAb (3.9) (preservative free) | ANC-160-820 | Ancell | Summary Details |
|
| anti-CD11c (human), mAb (3.9) (R-PE) | ANC-160-050 | Ancell | Summary Details |
|
| anti-CD122 (human), mAb (9A2) | ANC-343-020 | Ancell | Summary Details |
|
| anti-CD122 (human), mAb (9A2) (Biotin) | ANC-343-030 | Ancell | Summary Details |
|
| anti-CD122 (human), mAb (9A2) (preservative free) | ANC-343-820 | Ancell | Summary Details |
|
| anti-CD127 (human), mAb (ANC8F2) | ANC-348-020 | Ancell | Summary Details |
|
| anti-CD127 (human), mAb (ANC8F2) (Biotin) | ANC-348-030 | Ancell | Summary Details |
|
| anti-CD127 (human), mAb (ANC8F2) (FITC) | ANC-348-040 | Ancell | Summary Details |
|
| anti-CD127 (human), mAb (ANC8F2) (preservative free) | ANC-348-820 | Ancell | Summary Details |
|
| anti-CD127 (human), mAb (ANC8F2) (R-PE) | ANC-348-050 | Ancell | Summary Details |
|
| anti-CD13 (human), mAb (22A5) | ANC-162-020 | Ancell | Summary Details |
|
| anti-CD13 (human), mAb (22A5) (APC) | ANC-162-060 | Ancell | Summary Details |
|
| anti-CD13 (human), mAb (22A5) (Biotin) | ANC-162-030 | Ancell | Summary Details |
|
| anti-CD13 (human), mAb (22A5) (FITC) | ANC-162-040 | Ancell | Summary Details |
|
| anti-CD13 (human), mAb (22A5) (preservative free) | ANC-162-820 | Ancell | Summary Details |
|
| anti-CD13 (human), mAb (22A5) (R-PE) | ANC-162-050 | Ancell | Summary Details |
|
| anti-CD133 (human), mAb (ANC9C5) | ANC-363-020 | Ancell | Summary Details |
|
| anti-CD133 (human), mAb (ANC9C5) (APC) | ANC-363-060 | Ancell | Summary Details |
|
| anti-CD133 (human), mAb (ANC9C5) (Biotin) | ANC-363-030 | Ancell | Summary Details |
|
| anti-CD133 (human), mAb (ANC9C5) (FITC) | ANC-363-040 | Ancell | Summary Details |
|
| anti-CD133 (human), mAb (ANC9C5) (preservative free) | ANC-363-820 | Ancell | Summary Details |
|
| anti-CD133 (human), mAb (ANC9C5) (R-PE) | ANC-363-050 | Ancell | Summary Details |
|
| anti-CD134 [OX40] (human), mAb (BerAct35) | ANC-355-020 | Ancell | Summary Details |
|
| anti-CD134 [OX40] (human), mAb (BerAct35) (Biotin) | ANC-355-030 | Ancell | Summary Details |
|
| anti-CD134 [OX40] (human), mAb (BerAct35) (FITC) | ANC-355-040 | Ancell | Summary Details |
|
| anti-CD134 [OX40] (human), mAb (BerAct35) (preservative free) | ANC-355-820 | Ancell | Summary Details |
|
| anti-CD134 [OX40] (human), mAb (BerAct35) (R-PE) | ANC-355-050 | Ancell | Summary Details |
|
| anti-CD137 (human), mAb (4B4-1) | ANC-360-020 | Ancell | Summary Details |
|
| anti-CD137 (human), mAb (4B4-1) (Biotin) | ANC-360-030 | Ancell | Summary Details |
|
| anti-CD137 (human), mAb (4B4-1) (F(ab')2) | ANC-360-520 | Ancell | Summary Details |
|
| anti-CD137 (human), mAb (4B4-1) (Fab) | ANC-360-580 | Ancell | Summary Details |
|
| anti-CD137 (human), mAb (4B4-1) (FITC) | ANC-360-040 | Ancell | Summary Details |
|
| anti-CD137 (human), mAb (4B4-1) (preservative free) | ANC-360-820 | Ancell | Summary Details |
|
| anti-CD137 (human), mAb (4B4-1) (R-PE) | ANC-360-050 | Ancell | Summary Details |
|
| anti-CD137L (human), mAb (ANC5D6) | ANC-365-020 | Ancell | Summary Details |
|
| anti-CD137L (human), mAb (ANC5D6) (Biotin) | ANC-365-030 | Ancell | Summary Details |
|
| anti-CD137L (human), mAb (ANC5D6) (preservative free) | ANC-365-820 | Ancell | Summary Details |
|
| anti-CD137L (human), mAb (ANC5D6) (R-PE) | ANC-365-050 | Ancell | Summary Details |
|
| anti-CD14 (human), mAb (UCHM1) | ANC-163-020 | Ancell | Summary Details |
|
| anti-CD14 (human), mAb (UCHM1) (Biotin) | ANC-163-030 | Ancell | Summary Details |
|
| anti-CD14 (human), mAb (UCHM1) (FITC) | ANC-163-040 | Ancell | Summary Details |
|
| anti-CD14 (human), mAb (UCHM1) (preservative free) | ANC-163-820 | Ancell | Summary Details |
|
| anti-CD14 (human), mAb (UCHM1) (R-PE) | ANC-163-050 | Ancell | Summary Details |
|
| anti-CD147 (human), mAb (UM-8D6) | ANC-376-020 | Ancell | Summary Details |
|
| anti-CD147 (human), mAb (UM-8D6) (APC) | ANC-376-060 | Ancell | Summary Details |
|
| anti-CD147 (human), mAb (UM-8D6) (Biotin) | ANC-376-030 | Ancell | Summary Details |
|
| anti-CD147 (human), mAb (UM-8D6) (FITC) | ANC-376-040 | Ancell | Summary Details |
|
| anti-CD147 (human), mAb (UM-8D6) (preservative free) | ANC-376-820 | Ancell | Summary Details |
|
| anti-CD147 (human), mAb (UM-8D6) (R-PE) | ANC-376-050 | Ancell | Summary Details |
|
| anti-CD15 (human), mAb (AHN1.1) | ANC-164-020 | Ancell | Summary Details |
|
| anti-CD15 (human), mAb (AHN1.1) (Biotin) | ANC-164-030 | Ancell | Summary Details |
|
| anti-CD15 (human), mAb (AHN1.1) (FITC) | ANC-164-040 | Ancell | Summary Details |
|
| anti-CD15 (human), mAb (AHN1.1) (preservative free) | ANC-164-820 | Ancell | Summary Details |
|
| anti-CD152 (human), mAb (ANC152.2/8H5) | ANC-359-020 | Ancell | Summary Details |
|
| anti-CD152 (human), mAb (ANC152.2/8H5) (Biotin) | ANC-359-030 | Ancell | Summary Details |
|
| anti-CD152 (human), mAb (ANC152.2/8H5) (F(ab')2) | ANC-359-520 | Ancell | Summary Details |
|
| anti-CD152 (human), mAb (ANC152.2/8H5) (Fab) | ANC-359-580 | Ancell | Summary Details |
|
| anti-CD152 (human), mAb (ANC152.2/8H5) (FITC) | ANC-359-040 | Ancell | Summary Details |
|
| anti-CD152 (human), mAb (ANC152.2/8H5) (preservative free) | ANC-359-820 | Ancell | Summary Details |
|
| anti-CD152 (human), mAb (ANC152.2/8H5) (R-PE) | ANC-359-050 | Ancell | Summary Details |
|
| anti-CD152 [CTLA-4] (human), mAb (ANC152.2/8H5) (APC) | ANC-359-060 | Ancell | Summary Details |
|
| anti-CD154 (human), mAb (24-31) | ANC-353-020 | Ancell | Summary Details |
|
| anti-CD154 (human), mAb (24-31) (Biotin) | ANC-353-030 | Ancell | Summary Details |
|
| anti-CD154 (human), mAb (24-31) (FITC) | ANC-353-040 | Ancell | Summary Details |
|
| anti-CD154 (human), mAb (24-31) (preservative free) | ANC-353-820 | Ancell | Summary Details |
|
| anti-CD154 (human), mAb (24-31) (R-PE) | ANC-353-050 | Ancell | Summary Details |
|
| anti-CD155 (PVR) (human) mAb (ANC2B2) | ANC-255-020 | Ancell | Summary Details |
|
| anti-CD155 (PVR) (human) mAb (ANC2B2) (Biotin) | ANC-255-030 | Ancell | Summary Details |
|
| anti-CD155 (PVR) (human) mAb (ANC2B2) (FITC) | ANC-255-040 | Ancell | Summary Details |
|
| anti-CD155 (PVR) (human) mAb (ANC2B2) (preservative-free) | ANC-255-820 | Ancell | Summary Details |
|
| anti-CD155 (PVR) (human) mAb (ANC2B2) (R-PE) | ANC-255-050 | Ancell | Summary Details |
|
| anti-CD155 (PVR) (human), mAb (ANC6A3) | ANC-350-020 | Ancell | Summary Details |
|
| anti-CD155 (PVR) (human), mAb (ANC6A3) (Biotin) | ANC-350-030 | Ancell | Summary Details |
|
| anti-CD155 (PVR) (human), mAb (ANC6A3) (FITC) | ANC-350-040 | Ancell | Summary Details |
|
| anti-CD155 (PVR) (human), mAb (ANC6A3) (preservative free) | ANC-350-820 | Ancell | Summary Details |
|
| anti-CD155 (PVR) (human), mAb (ANC6A3) (R-PE) | ANC-350-050 | Ancell | Summary Details |
|
| anti-CD16 (human), mAb (3G8) | ANC-165-020 | Ancell | Summary Details |
|
| anti-CD16 (human), mAb (3G8) (Biotin) | ANC-165-030 | Ancell | Summary Details |
|
| anti-CD16 (human), mAb (3G8) (F(ab')2) | ANC-165-520 | Ancell | Summary Details |
|
| anti-CD16 (human), mAb (3G8) (Fab) | ANC-165-580 | Ancell | Summary Details |
|
| anti-CD16 (human), mAb (3G8) (Fab) (Biotin) | ANC-165-530 | Ancell | Summary Details |
|
| anti-CD16 (human), mAb (3G8) (FITC) | ANC-165-040 | Ancell | Summary Details |
|
| anti-CD16 (human), mAb (3G8) (preservative free) | ANC-165-820 | Ancell | Summary Details |
|
| anti-CD16 (human), mAb (3G8) (R-PE) | ANC-165-050 | Ancell | Summary Details |
|
| anti-CD161 [NKR-P1A] (human), mAb (B199.2) | ANC-388-020 | Ancell | Summary Details |
|
| anti-CD161 [NKR-P1A] (human), mAb (B199.2) (Biotin) | ANC-388-030 | Ancell | Summary Details |
|
| anti-CD161 [NKR-P1A] (human), mAb (B199.2) (FITC) | ANC-388-040 | Ancell | Summary Details |
|
| anti-CD161 [NKR-P1A] (human), mAb (B199.2) (preservative free) | ANC-388-820 | Ancell | Summary Details |
|
| anti-CD161 [NKR-P1A] (human), mAb (B199.2) (R-PE) | ANC-388-050 | Ancell | Summary Details |
|
| anti-CD165 (human), mAb (AD2) | ANC-392-020 | Ancell | Summary Details |
|
| anti-CD165 (human), mAb (AD2) (Biotin) | ANC-392-030 | Ancell | Summary Details |
|
| anti-CD165 (human), mAb (AD2) (FITC) | ANC-392-040 | Ancell | Summary Details |
|
| anti-CD165 (human), mAb (AD2) (preservative free) | ANC-392-820 | Ancell | Summary Details |
|
| anti-CD165 (human), mAb (AD2) (R-PE) | ANC-392-050 | Ancell | Summary Details |
|
| anti-CD166 (human), mAb (3A6) | ANC-393-020 | Ancell | Summary Details |
|
| anti-CD166 (human), mAb (3A6) (Biotin) | ANC-393-030 | Ancell | Summary Details |
|
| anti-CD166 (human), mAb (3A6) (FITC) | ANC-393-040 | Ancell | Summary Details |
|
| anti-CD166 (human), mAb (3A6) (preservative free) | ANC-393-820 | Ancell | Summary Details |
|
| anti-CD166 (human), mAb (3A6) (R-PE) | ANC-393-050 | Ancell | Summary Details |
|
| anti-CD17 (human), mAb (Huly-m13) | ANC-166-020 | Ancell | Summary Details |
|
| anti-CD17 (human), mAb (Huly-m13) (Biotin) | ANC-166-030 | Ancell | Summary Details |
|
| anti-CD17 (human), mAb (Huly-m13) (FITC) | ANC-166-040 | Ancell | Summary Details |
|
| anti-CD17 (human), mAb (Huly-m13) (preservative free) | ANC-166-820 | Ancell | Summary Details |
|
| anti-CD18 (human), mAb (IB4) | ANC-167-020 | Ancell | Summary Details |
|
| anti-CD18 (human), mAb (IB4) (Biotin) | ANC-167-030 | Ancell | Summary Details |
|
| anti-CD18 (human), mAb (IB4) (F(ab')2) | ANC-167-520 | Ancell | Summary Details |
|
| anti-CD18 (human), mAb (IB4) (Fab) | ANC-167-580 | Ancell | Summary Details |
|
| anti-CD18 (human), mAb (IB4) (FITC) | ANC-167-040 | Ancell | Summary Details |
|
| anti-CD18 (human), mAb (IB4) (preservative free) | ANC-167-820 | Ancell | Summary Details |
|
| anti-CD18 (human), mAb (IB4) (R-PE) | ANC-167-050 | Ancell | Summary Details |
|
| anti-CD19 (human), mAb (BU12) | ANC-168-020 | Ancell | Summary Details |
|
| anti-CD19 (human), mAb (BU12) (APC) | ANC-168-060 | Ancell | Summary Details |
|
| anti-CD19 (human), mAb (BU12) (Biotin) | ANC-168-030 | Ancell | Summary Details |
|
| anti-CD19 (human), mAb (BU12) (FITC) | ANC-168-040 | Ancell | Summary Details |
|
| anti-CD19 (human), mAb (BU12) (preservative free) | ANC-168-820 | Ancell | Summary Details |
|
| anti-CD19 (human), mAb (BU12) (R-PE) | ANC-168-050 | Ancell | Summary Details |
|
| anti-CD1a (human), mAb (CB-T6) | ANC-145-020 | Ancell | Summary Details |
|
| anti-CD1a (human), mAb (CB-T6) (Biotin) | ANC-145-030 | Ancell | Summary Details |
|
| anti-CD1a (human), mAb (CB-T6) (FITC) | ANC-145-040 | Ancell | Summary Details |
|
| anti-CD1a (human), mAb (CB-T6) (preservative free) | ANC-145-820 | Ancell | Summary Details |
|
| anti-CD1a (human), mAb (CB-T6) (R-PE) | ANC-145-050 | Ancell | Summary Details |
|
| anti-CD1b (human), mAb (SN13) | ANC-142-020 | Ancell | Summary Details |
|
| anti-CD1b (human), mAb (SN13) (Biotin) | ANC-142-030 | Ancell | Summary Details |
|
| anti-CD1b (human), mAb (SN13) (FITC) | ANC-142-040 | Ancell | Summary Details |
|
| anti-CD1b (human), mAb (SN13) (preservative free) | ANC-142-820 | Ancell | Summary Details |
|
| anti-CD1b (human), mAb (SN13) (R-PE) | ANC-142-050 | Ancell | Summary Details |
|
| anti-CD1c (human), mAb (M241) | ANC-146-020 | Ancell | Summary Details |
|
| anti-CD1c (human), mAb (M241) (Biotin) | ANC-146-030 | Ancell | Summary Details |
|
| anti-CD1c (human), mAb (M241) (FITC) | ANC-146-040 | Ancell | Summary Details |
|
| anti-CD1c (human), mAb (M241) (preservative free) | ANC-146-820 | Ancell | Summary Details |
|
| anti-CD1c (human), mAb (M241) (R-PE) | ANC-146-050 | Ancell | Summary Details |
|
| anti-CD2 (human), mAb (1E7E8) | ANC-143-020 | Ancell | Summary Details |
|
| anti-CD2 (human), mAb (1E7E8) (Biotin) | ANC-143-030 | Ancell | Summary Details |
|
| anti-CD2 (human), mAb (1E7E8) (FITC) | ANC-143-040 | Ancell | Summary Details |
|
| anti-CD2 (human), mAb (1E7E8) (preservative free) | ANC-143-820 | Ancell | Summary Details |
|
| anti-CD2 (human), mAb (1E7E8) (R-PE) | ANC-143-050 | Ancell | Summary Details |
|
| anti-CD21 (human), mAb (BU33) | ANC-170-020 | Ancell | Summary Details |
|
| anti-CD21 (human), mAb (BU33) (Biotin) | ANC-170-030 | Ancell | Summary Details |
|
| anti-CD21 (human), mAb (BU33) (FITC) | ANC-170-040 | Ancell | Summary Details |
|
| anti-CD21 (human), mAb (BU33) (preservative free) | ANC-170-820 | Ancell | Summary Details |
|
| anti-CD21 (human), mAb (BU33) (R-PE) | ANC-170-050 | Ancell | Summary Details |
|
| anti-CD22 (human), mAb (RFB4) | ANC-171-020 | Ancell | Summary Details |
|
| anti-CD22 (human), mAb (RFB4) (Biotin) | ANC-171-030 | Ancell | Summary Details |
|
| anti-CD22 (human), mAb (RFB4) (FITC) | ANC-171-040 | Ancell | Summary Details |
|
| anti-CD22 (human), mAb (RFB4) (preservative free) | ANC-171-820 | Ancell | Summary Details |
|
| anti-CD22 (human), mAb (RFB4) (R-PE) | ANC-171-050 | Ancell | Summary Details |
|
| anti-CD23 (human), mAb (BU38) | ANC-172-020 | Ancell | Summary Details |
|
| anti-CD23 (human), mAb (BU38) (Biotin) | ANC-172-030 | Ancell | Summary Details |
|
| anti-CD23 (human), mAb (BU38) (FITC) | ANC-172-040 | Ancell | Summary Details |
|
| anti-CD23 (human), mAb (BU38) (preservative free) | ANC-172-820 | Ancell | Summary Details |
|
| anti-CD23 (human), mAb (BU38) (R-PE) | ANC-172-050 | Ancell | Summary Details |
|
| anti-CD235 [Glycophorin A] (human), mAb (A63-B/C2) | ANC-122-020 | Ancell | Summary Details |
|
| anti-CD235 [Glycophorin A] (human), mAb (A63-B/C2) (Biotin) | ANC-122-030 | Ancell | Summary Details |
|
| anti-CD235 [Glycophorin A] (human), mAb (A63-B/C2) (FITC) | ANC-122-040 | Ancell | Summary Details |
|
| anti-CD235 [Glycophorin A] (human), mAb (A63-B/C2) (preservative free) | ANC-122-820 | Ancell | Summary Details |
|
| anti-CD24 (human), mAb (BA-1) | ANC-173-020 | Ancell | Summary Details |
|
| anti-CD24 (human), mAb (BA-1) (Biotin) | ANC-173-030 | Ancell | Summary Details |
|
| anti-CD24 (human), mAb (BA-1) (FITC) | ANC-173-040 | Ancell | Summary Details |
|
| anti-CD24 (human), mAb (BA-1) (preservative free) | ANC-173-820 | Ancell | Summary Details |
|
| anti-CD244 (human), mAb (ANC2B4/3B12) | ANC-259-020 | Ancell | Summary Details |
|
| anti-CD244 (human), mAb (ANC2B4/3B12) (FITC) | ANC-259-040 | Ancell | Summary Details |
|
| anti-CD244 (human), mAb (ANC2B4/3B12) (preservative free) | ANC-259-820 | Ancell | Summary Details |
|
| anti-CD244 [2B4] (human), mAb (2B4) (Biotin) (ANC244.8/8F7) | ANC-239-030 | Ancell | Summary Details |
|
| anti-CD244 [2B4] (human), mAb (2B4) (FITC) (ANC244.8/8F7) | ANC-239-040 | Ancell | Summary Details |
|
| anti-CD244 [2B4] (human), mAb (2B4) (R-PE) (ANC244.8/8F7) | ANC-239-050 | Ancell | Summary Details |
|
| anti-CD244 [2B4] (human), mAb (ANC244.8/8F7) | ANC-239-020 | Ancell | Summary Details |
|
| anti-CD244 [2B4] (human), mAb (ANC244.8/8F7) (preservative free) | ANC-239-820 | Ancell | Summary Details |
|
| anti-CD25 (human), mAb (7G7B6) | ANC-174-020 | Ancell | Summary Details |
|
| anti-CD25 (human), mAb (7G7B6) (APC) | ANC-174-060 | Ancell | Summary Details |
|
| anti-CD25 (human), mAb (7G7B6) (Biotin) | ANC-174-030 | Ancell | Summary Details |
|
| anti-CD25 (human), mAb (7G7B6) (FITC) | ANC-174-040 | Ancell | Summary Details |
|
| anti-CD25 (human), mAb (7G7B6) (preservative free) | ANC-174-820 | Ancell | Summary Details |
|
| anti-CD25 (human), mAb (7G7B6) (R-PE) | ANC-174-050 | Ancell | Summary Details |
|
| anti-CD252 [OX40L] (human), mAb (ANC10G1) | ANC-400-020 | Ancell | Summary Details |
|
| anti-CD252 [OX40L] (human), mAb (ANC10G1) (APC) | ANC-400-060 | Ancell | Summary Details |
|
| anti-CD252 [OX40L] (human), mAb (ANC10G1) (Biotin) | ANC-400-030 | Ancell | Summary Details |
|
| anti-CD252 [OX40L] (human), mAb (ANC10G1) (FITC) | ANC-400-040 | Ancell | Summary Details |
|
| anti-CD252 [OX40L] (human), mAb (ANC10G1) (preservative free) | ANC-400-820 | Ancell | Summary Details |
|
| anti-CD252 [OX40L] (human), mAb (ANC10G1) (R-PE) | ANC-400-050 | Ancell | Summary Details |
|
| anti-CD257 [BAFF] (human), mAb (ANC2H3) | ANC-266-020 | Ancell | Summary Details |
|
| anti-CD257 [BAFF] (human), mAb (ANC2H3) (Biotin) | ANC-266-030 | Ancell | Summary Details |
|
| anti-CD257 [BAFF] (human), mAb (ANC2H3) (FITC) | ANC-266-040 | Ancell | Summary Details |
|
| anti-CD257 [BAFF] (human), mAb (ANC2H3) (preservative free) | ANC-266-820 | Ancell | Summary Details |
|
| anti-CD257 [BAFF] (human), mAb (ANC2H3) (R-PE) | ANC-266-050 | Ancell | Summary Details |
|
| anti-CD26 (human), mAb (202.36) | ANC-175-020 | Ancell | Summary Details |
|
| anti-CD26 (human), mAb (202.36) (Biotin) | ANC-175-030 | Ancell | Summary Details |
|
| anti-CD26 (human), mAb (202.36) (FITC) | ANC-175-040 | Ancell | Summary Details |
|
| anti-CD26 (human), mAb (202.36) (preservative free) | ANC-175-820 | Ancell | Summary Details |
|
| anti-CD26 (human), mAb (202.36) (R-PE) | ANC-175-050 | Ancell | Summary Details |
|
| anti-CD268 [BAFF-R] (human), mAb (ANC268.2/6E6) | ANC-275-020 | Ancell | Summary Details |
|
| anti-CD268 [BAFF-R] (human), mAb (ANC268.2/6E6) (Biotin) | ANC-275-030 | Ancell | Summary Details |
|
| anti-CD268 [BAFF-R] (human), mAb (ANC268.2/6E6) (FITC) | ANC-275-040 | Ancell | Summary Details |
|
| anti-CD268 [BAFF-R] (human), mAb (ANC268.2/6E6) (preservative free) | ANC-275-820 | Ancell | Summary Details |
|
| anti-CD268 [BAFF-R] (human), mAb (ANC268.2/6E6) (R-PE) | ANC-275-050 | Ancell | Summary Details |
|
| anti-CD269 [BCMA] (human), mAb (ANC3B1) | ANC-269-020 | Ancell | Summary Details |
|
| anti-CD269 [BCMA] (human), mAb (ANC3B1) (Biotin) | ANC-269-030 | Ancell | Summary Details |
|
| anti-CD269 [BCMA] (human), mAb (ANC3B1) (preservative free) | ANC-269-820 | Ancell | Summary Details |
|
| anti-CD269 [BCMA] (human), mAb (ANC3B1) (R-PE) | ANC-269-050 | Ancell | Summary Details |
|
| anti-CD27 (human), mAb (M-T271) | ANC-176-020 | Ancell | Summary Details |
|
| anti-CD27 (human), mAb (M-T271) (Biotin) | ANC-176-030 | Ancell | Summary Details |
|
| anti-CD27 (human), mAb (M-T271) (FITC) | ANC-176-040 | Ancell | Summary Details |
|
| anti-CD27 (human), mAb (M-T271) (preservative free) | ANC-176-820 | Ancell | Summary Details |
|
| anti-CD27 (human), mAb (M-T271) (R-PE) | ANC-176-050 | Ancell | Summary Details |
|
| anti-CD270 [HVEM] (human), mAb (ANC3B7) | ANC-270-020 | Ancell | Summary Details |
|
| anti-CD270 [HVEM] (human), mAb (ANC3B7) (Biotin) | ANC-270-030 | Ancell | Summary Details |
|
| anti-CD270 [HVEM] (human), mAb (ANC3B7) (FITC) | ANC-270-040 | Ancell | Summary Details |
|
| anti-CD270 [HVEM] (human), mAb (ANC3B7) (preservative free) | ANC-270-820 | Ancell | Summary Details |
|
| anti-CD270 [HVEM] (human), mAb (ANC3B7) (R-PE) | ANC-270-050 | Ancell | Summary Details |
|
| anti-CD271 [NGFR] (human), mAb (ANC271/3D7) | ANC-271-020 | Ancell | Summary Details |
|
| anti-CD271 [NGFR] (human), mAb (ANC271/3D7) (Biotin) | ANC-271-030 | Ancell | Summary Details |
|
| anti-CD271 [NGFR] (human), mAb (ANC271/3D7) (FITC) | ANC-271-040 | Ancell | Summary Details |
|
| anti-CD271 [NGFR] (human), mAb (ANC271/3D7) (preservative free) | ANC-271-820 | Ancell | Summary Details |
|
| anti-CD272 [BTLA] (human), mAb (ANC5A5) | ANC-372-020 | Ancell | Summary Details |
|
| anti-CD272 [BTLA] (human), mAb (ANC5A5) (Biotin) | ANC-372-030 | Ancell | Summary Details |
|
| anti-CD272 [BTLA] (human), mAb (ANC5A5) (FITC) | ANC-372-040 | Ancell | Summary Details |
|
| anti-CD272 [BTLA] (human), mAb (ANC5A5) (preservative free) | ANC-372-820 | Ancell | Summary Details |
|
| anti-CD272 [BTLA] (human), mAb (ANC5A5) (R-PE) | ANC-372-050 | Ancell | Summary Details |
|
| anti-CD272 [BTLA] (human), mAb (ANC6E9) | ANC-272-020 | Ancell | Summary Details |
|
| anti-CD272 [BTLA] (human), mAb (ANC6E9) (APC) | ANC-272-060 | Ancell | Summary Details |
|
| anti-CD272 [BTLA] (human), mAb (ANC6E9) (Biotin) | ANC-272-030 | Ancell | Summary Details |
|
| anti-CD272 [BTLA] (human), mAb (ANC6E9) (FITC) | ANC-272-040 | Ancell | Summary Details |
|
| anti-CD272 [BTLA] (human), mAb (ANC6E9) (preservative free) | ANC-272-820 | Ancell | Summary Details |
|
| anti-CD272 [BTLA] (human), mAb (ANC6E9) (R-PE) | ANC-272-050 | Ancell | Summary Details |
|
| anti-CD273 [B7-DC/PD-L2] (human), mAb (ANC8D12) | ANC-273-020 | Ancell | Summary Details |
|
| anti-CD273 [B7-DC/PD-L2] (human), mAb (ANC8D12) (Biotin) | ANC-273-030 | Ancell | Summary Details |
|
| anti-CD273 [B7-DC/PD-L2] (human), mAb (ANC8D12) (FITC) | ANC-273-040 | Ancell | Summary Details |
|
| anti-CD273 [B7-DC/PD-L2] (human), mAb (ANC8D12) (preservative free) | ANC-273-820 | Ancell | Summary Details |
|
| anti-CD274 [B7-H1] (human), mAb (ANC6H1) | ANC-274-020 | Ancell | Summary Details |
|
| anti-CD274 [B7-H1] (human), mAb (ANC6H1) (Biotin) | ANC-274-030 | Ancell | Summary Details |
|
| anti-CD274 [B7-H1] (human), mAb (ANC6H1) (preservative free) | ANC-274-820 | Ancell | Summary Details |
|
| anti-CD274 [B7-H1/PD-L1] (human), mAb (ANC6H1) (FITC) | ANC-274-040 | Ancell | Summary Details |
|
| anti-CD274 [B7-H1/PD-L1] (human), mAb (ANC6H1) (R-PE) | ANC-274-050 | Ancell | Summary Details |
|
| anti-CD275 (human), mAb (ANC4E3) | ANC-263-020 | Ancell | Summary Details |
|
| anti-CD275 (human), mAb (ANC4E3) (Biotin) | ANC-263-030 | Ancell | Summary Details |
|
| anti-CD275 (human), mAb (ANC4E3) (preservative free) | ANC-263-820 | Ancell | Summary Details |
|
| anti-CD278 [ICOS] (human), mAb (ANC6C6) | ANC-265-020 | Ancell | Summary Details |
|
| anti-CD278 [ICOS] (human), mAb (ANC6C6) (APC) | ANC-265-060 | Ancell | Summary Details |
|
| anti-CD278 [ICOS] (human), mAb (ANC6C6) (Biotin) | ANC-265-030 | Ancell | Summary Details |
|
| anti-CD278 [ICOS] (human), mAb (ANC6C6) (FITC) | ANC-265-040 | Ancell | Summary Details |
|
| anti-CD278 [ICOS] (human), mAb (ANC6C6) (preservative free) | ANC-265-820 | Ancell | Summary Details |
|
| anti-CD278 [ICOS] (human), mAb (ANC6C6) (R-PE) | ANC-265-050 | Ancell | Summary Details |
|
| anti-CD279 [PD-1] (human), mAb (ANC4H6) | ANC-279-020 | Ancell | Summary Details |
|
| anti-CD279 [PD-1] (human), mAb (ANC4H6) (Biotin) | ANC-279-030 | Ancell | Summary Details |
|
| anti-CD279 [PD-1] (human), mAb (ANC4H6) (FITC) | ANC-279-040 | Ancell | Summary Details |
|
| anti-CD279 [PD-1] (human), mAb (ANC4H6) (preservative free) | ANC-279-820 | Ancell | Summary Details |
|
| anti-CD28 (human), mAb (ANC28.1/5D10) | ANC-177-020 | Ancell | Summary Details |
|
| anti-CD28 (human), mAb (ANC28.1/5D10) (Biotin) | ANC-177-030 | Ancell | Summary Details |
|
| anti-CD28 (human), mAb (ANC28.1/5D10) (F(ab')2) | ANC-177-520 | Ancell | Summary Details |
|
| anti-CD28 (human), mAb (ANC28.1/5D10) (FITC) | ANC-177-040 | Ancell | Summary Details |
|
| anti-CD28 (human), mAb (ANC28.1/5D10) (preservative free) | ANC-177-820 | Ancell | Summary Details |
|
| anti-CD28 (human), mAb (ANC28.1/5D10) (R-PE) | ANC-177-050 | Ancell | Summary Details |
|
| anti-CD29 (human), mAb (4B7R) | ANC-178-020 | Ancell | Summary Details |
|
| anti-CD29 (human), mAb (4B7R) (Biotin) | ANC-178-030 | Ancell | Summary Details |
|
| anti-CD29 (human), mAb (4B7R) (FITC) | ANC-178-040 | Ancell | Summary Details |
|
| anti-CD29 (human), mAb (4B7R) (preservative free) | ANC-178-820 | Ancell | Summary Details |
|
| anti-CD29 (human), mAb (4B7R) (R-PE) | ANC-178-050 | Ancell | Summary Details |
|
| anti-CD3 (human), mAb (UCHT1) | ANC-144-020 | Ancell | Summary Details |
|
| anti-CD3 (human), mAb (UCHT1) (APC) | ANC-144-060 | Ancell | Summary Details |
|
| anti-CD3 (human), mAb (UCHT1) (Biotin) | ANC-144-030 | Ancell | Summary Details |
|
| anti-CD3 (human), mAb (UCHT1) (F(ab')2) | ANC-144-520 | Ancell | Summary Details |
|
| anti-CD3 (human), mAb (UCHT1) (Fab) | ANC-144-580 | Ancell | Summary Details |
|
| anti-CD3 (human), mAb (UCHT1) (FITC) | ANC-144-040 | Ancell | Summary Details |
|
| anti-CD3 (human), mAb (UCHT1) (preservative free) | ANC-144-820 | Ancell | Summary Details |
|
| anti-CD3 (human), mAb (UCHT1) (R-PE) | ANC-144-050 | Ancell | Summary Details |
|
| anti-CD3 (mouse), mAb (145-2C11) | ANC-703-020 | Ancell | Summary Details |
|
| anti-CD3 (mouse), mAb (145-2C11) (APC) | ANC-703-060 | Ancell | Summary Details |
|
| anti-CD3 (mouse), mAb (145-2C11) (Biotin) | ANC-703-030 | Ancell | Summary Details |
|
| anti-CD3 (mouse), mAb (145-2C11) (FITC) | ANC-703-040 | Ancell | Summary Details |
|
| anti-CD3 (mouse), mAb (145-2C11) (preservative free) | ANC-703-820 | Ancell | Summary Details |
|
| anti-CD3 (mouse), mAb (145-2C11) (R-PE) | ANC-703-050 | Ancell | Summary Details |
|
| anti-CD30 (human), mAb (AC10) | ANC-179-020 | Ancell | Summary Details |
|
| anti-CD30 (human), mAb (AC10) (APC) | ANC-179-060 | Ancell | Summary Details |
|
| anti-CD30 (human), mAb (AC10) (Biotin) | ANC-179-030 | Ancell | Summary Details |
|
| anti-CD30 (human), mAb (AC10) (preservative free) | ANC-179-820 | Ancell | Summary Details |
|
| anti-CD30 (human), mAb (AC10) (R-PE) | ANC-179-050 | Ancell | Summary Details |
|
| anti-CD31 (human), mAb (158-2B3) | ANC-180-020 | Ancell | Summary Details |
|
| anti-CD31 (human), mAb (158-2B3) (Biotin) | ANC-180-030 | Ancell | Summary Details |
|
| anti-CD31 (human), mAb (158-2B3) (FITC) | ANC-180-040 | Ancell | Summary Details |
|
| anti-CD31 (human), mAb (158-2B3) (preservative free) | ANC-180-820 | Ancell | Summary Details |
|
| anti-CD31 (human), mAb (158-2B3) (R-PE) | ANC-180-050 | Ancell | Summary Details |
|
| anti-CD32 (human), mAb (7.3) | ANC-181-020 | Ancell | Summary Details |
|
| anti-CD32 (human), mAb (7.3) (Biotin) | ANC-181-030 | Ancell | Summary Details |
|
| anti-CD32 (human), mAb (7.3) (F(ab')2) | ANC-181-520 | Ancell | Summary Details |
|
| anti-CD32 (human), mAb (7.3) (Fab) | ANC-181-580 | Ancell | Summary Details |
|
| anti-CD32 (human), mAb (7.3) (preservative free) | ANC-181-820 | Ancell | Summary Details |
|
| anti-CD32 (human), mAb (7.3) (R-PE) | ANC-181-050 | Ancell | Summary Details |
|
| anti-CD326 (human), mAb (ANC8D4) | ANC-126-020 | Ancell | Summary Details |
|
| anti-CD326 (human), mAb (ANC8D4) (Biotin) | ANC-126-030 | Ancell | Summary Details |
|
| anti-CD326 (human), mAb (ANC8D4) (FITC) | ANC-126-040 | Ancell | Summary Details |
|
| anti-CD326 (human), mAb (ANC8D4) (preservative free) | ANC-126-820 | Ancell | Summary Details |
|
| anti-CD326 (human), mAb (ANC8D4) (R-PE) | ANC-126-050 | Ancell | Summary Details |
|
| anti-CD34 (human), mAb (43A1) | ANC-183-020 | Ancell | Summary Details |
|
| anti-CD34 (human), mAb (43A1) (APC) | ANC-183-060 | Ancell | Summary Details |
|
| anti-CD34 (human), mAb (43A1) (Biotin) | ANC-183-030 | Ancell | Summary Details |
|
| anti-CD34 (human), mAb (43A1) (FITC) | ANC-183-040 | Ancell | Summary Details |
|
| anti-CD34 (human), mAb (43A1) (preservative free) | ANC-183-820 | Ancell | Summary Details |
|
| anti-CD34 (human), mAb (43A1) (R-PE) | ANC-183-050 | Ancell | Summary Details |
|
| anti-CD35 (human), mAb (E11) | ANC-184-020 | Ancell | Summary Details |
|
| anti-CD35 (human), mAb (E11) (Biotin) | ANC-184-030 | Ancell | Summary Details |
|
| anti-CD35 (human), mAb (E11) (FITC) | ANC-184-040 | Ancell | Summary Details |
|
| anti-CD35 (human), mAb (E11) (preservative free) | ANC-184-820 | Ancell | Summary Details |
|
| anti-CD35 (human), mAb (E11) (R-PE) | ANC-184-050 | Ancell | Summary Details |
|
| anti-CD357 [GITR] (human), mAb (ANC5E3) | ANC-368-020 | Ancell | Summary Details |
|
| anti-CD357 [GITR] (human), mAb (ANC5E3) (Biotin) | ANC-368-030 | Ancell | Summary Details |
|
| anti-CD357 [GITR] (human), mAb (ANC5E3) (FITC) | ANC-368-040 | Ancell | Summary Details |
|
| anti-CD357 [GITR] (human), mAb (ANC5E3) (preservative free) | ANC-368-820 | Ancell | Summary Details |
|
| anti-CD357 [GITR] (human), mAb (ANC5E3) (R-PE) | ANC-368-050 | Ancell | Summary Details |
|
| anti-CD357 [GITR] (human), mAb (ANC7D6) | ANC-268-020 | Ancell | Summary Details |
|
| anti-CD357 [GITR] (human), mAb (ANC7D6) (Biotin) | ANC-268-030 | Ancell | Summary Details |
|
| anti-CD357 [GITR] (human), mAb (ANC7D6) (FITC) | ANC-268-040 | Ancell | Summary Details |
|
| anti-CD357 [GITR] (human), mAb (ANC7D6) (preservative free) | ANC-268-820 | Ancell | Summary Details |
|
| anti-CD36 (human), mAb (SMO) | ANC-185-020 | Ancell | Summary Details |
|
| anti-CD36 (human), mAb (SMO) (Biotin) | ANC-185-030 | Ancell | Summary Details |
|
| anti-CD36 (human), mAb (SMO) (FITC) | ANC-185-040 | Ancell | Summary Details |
|
| anti-CD36 (human), mAb (SMO) (preservative free) | ANC-185-820 | Ancell | Summary Details |
|
| anti-CD37 (human), mAb (IPO-24) | ANC-186-020 | Ancell | Summary Details |
|
| anti-CD37 (human), mAb (IPO-24) (Biotin) | ANC-186-030 | Ancell | Summary Details |
|
| anti-CD37 (human), mAb (IPO-24) (FITC) | ANC-186-040 | Ancell | Summary Details |
|
| anti-CD37 (human), mAb (IPO-24) (preservative free) | ANC-186-820 | Ancell | Summary Details |
|
| anti-CD37 (human), mAb (IPO-24) (R-PE) | ANC-186-050 | Ancell | Summary Details |
|
| anti-CD38 (human), mAb (AT1) | ANC-187-020 | Ancell | Summary Details |
|
| anti-CD38 (human), mAb (AT1) (APC) | ANC-187-060 | Ancell | Summary Details |
|
| anti-CD38 (human), mAb (AT1) (Biotin) | ANC-187-030 | Ancell | Summary Details |
|
| anti-CD38 (human), mAb (AT1) (FITC) | ANC-187-040 | Ancell | Summary Details |
|
| anti-CD38 (human), mAb (AT1) (preservative free) | ANC-187-820 | Ancell | Summary Details |
|
| anti-CD38 (human), mAb (AT1) (R-PE) | ANC-187-050 | Ancell | Summary Details |
|
| anti-CD39 (human), mAb (BU61) | ANC-188-020 | Ancell | Summary Details |
|
| anti-CD39 (human), mAb (BU61) (Biotin) | ANC-188-030 | Ancell | Summary Details |
|
| anti-CD39 (human), mAb (BU61) (FITC) | ANC-188-040 | Ancell | Summary Details |
|
| anti-CD39 (human), mAb (BU61) (preservative free) | ANC-188-820 | Ancell | Summary Details |
|
| anti-CD39 (human), mAb (BU61) (R-PE) | ANC-188-050 | Ancell | Summary Details |
|
| anti-CD4 (human), mAb (M-T441) | ANC-148-020 | Ancell | Summary Details |
|
| anti-CD4 (human), mAb (M-T441) (APC) | ANC-148-060 | Ancell | Summary Details |
|
| anti-CD4 (human), mAb (M-T441) (Biotin) | ANC-148-030 | Ancell | Summary Details |
|
| anti-CD4 (human), mAb (M-T441) (FITC) | ANC-148-040 | Ancell | Summary Details |
|
| anti-CD4 (human), mAb (M-T441) (preservative free) | ANC-148-820 | Ancell | Summary Details |
|
| anti-CD4 (human), mAb (M-T441) (R-PE) | ANC-148-050 | Ancell | Summary Details |
|
| anti-CD4 (human), mAb (QS4120) | ANC-147-020 | Ancell | Summary Details |
|
| anti-CD4 (human), mAb (QS4120) (APC) | ANC-147-060 | Ancell | Summary Details |
|
| anti-CD4 (human), mAb (QS4120) (Biotin) | ANC-147-030 | Ancell | Summary Details |
|
| anti-CD4 (human), mAb (QS4120) (FITC) | ANC-147-040 | Ancell | Summary Details |
|
| anti-CD4 (human), mAb (QS4120) (PE-Cy7) | ANC-147-070 | Ancell | Summary Details |
|
| anti-CD4 (human), mAb (QS4120) (preservative free) | ANC-147-820 | Ancell | Summary Details |
|
| anti-CD4 (human), mAb (QS4120) (R-PE) | ANC-147-050 | Ancell | Summary Details |
|
| anti-CD4 (mouse), mAb (GK1.5) | ANC-704-020 | Ancell | Summary Details |
|
| anti-CD4 (mouse), mAb (GK1.5) (APC) | ANC-704-060 | Ancell | Summary Details |
|
| anti-CD4 (mouse), mAb (GK1.5) (Biotin) | ANC-704-030 | Ancell | Summary Details |
|
| anti-CD4 (mouse), mAb (GK1.5) (FITC) | ANC-704-040 | Ancell | Summary Details |
|
| anti-CD4 (mouse), mAb (GK1.5) (PE-Cy7) | ANC-704-070 | Ancell | Summary Details |
|
| anti-CD4 (mouse), mAb (GK1.5) (preservative free) | ANC-704-820 | Ancell | Summary Details |
|
| anti-CD4 (mouse), mAb (GK1.5) (R-PE) | ANC-704-050 | Ancell | Summary Details |
|
| anti-CD40 (human), mAb (BE-1) | ANC-189-020 | Ancell | Summary Details |
|
| anti-CD40 (human), mAb (BE-1) (Biotin) | ANC-189-030 | Ancell | Summary Details |
|
| anti-CD40 (human), mAb (BE-1) (preservative free) | ANC-189-820 | Ancell | Summary Details |
|
| anti-CD40 (human), mAb (BE-1) (R-PE) | ANC-189-050 | Ancell | Summary Details |
|
| anti-CD40 (human), mAb (EA-5) | ANC-300-020 | Ancell | Summary Details |
|
| anti-CD40 (human), mAb (EA-5) (APC) | ANC-300-060 | Ancell | Summary Details |
|
| anti-CD40 (human), mAb (EA-5) (Biotin) | ANC-300-030 | Ancell | Summary Details |
|
| anti-CD40 (human), mAb (EA-5) (FITC) | ANC-300-040 | Ancell | Summary Details |
|
| anti-CD40 (human), mAb (EA-5) (preservative free) | ANC-300-820 | Ancell | Summary Details |
|
| anti-CD40 (human), mAb (EA-5) (R-PE) | ANC-300-050 | Ancell | Summary Details |
|
| anti-CD41a (human), mAb (96.2C1) | ANC-190-020 | Ancell | Summary Details |
|
| anti-CD41a (human), mAb (96.2C1) (Biotin) | ANC-190-030 | Ancell | Summary Details |
|
| anti-CD41a (human), mAb (96.2C1) (FITC) | ANC-190-040 | Ancell | Summary Details |
|
| anti-CD41a (human), mAb (96.2C1) (preservative free) | ANC-190-820 | Ancell | Summary Details |
|
| anti-CD41a (human), mAb (96.2C1) (R-PE) | ANC-190-050 | Ancell | Summary Details |
|
| anti-CD43 (human), mAb (DFT1) | ANC-192-020 | Ancell | Summary Details |
|
| anti-CD43 (human), mAb (DFT1) (Biotin) | ANC-192-030 | Ancell | Summary Details |
|
| anti-CD43 (human), mAb (DFT1) (FITC) | ANC-192-040 | Ancell | Summary Details |
|
| anti-CD43 (human), mAb (DFT1) (preservative free) | ANC-192-820 | Ancell | Summary Details |
|
| anti-CD43 (human), mAb (DFT1) (R-PE) | ANC-192-050 | Ancell | Summary Details |
|
| anti-CD44 (human), mAb (BU52) | ANC-193-020 | Ancell | Summary Details |
|
| anti-CD44 (human), mAb (BU52) (Biotin) | ANC-193-030 | Ancell | Summary Details |
|
| anti-CD44 (human), mAb (BU52) (F(ab')2) | ANC-193-520 | Ancell | Summary Details |
|
| anti-CD44 (human), mAb (BU52) (Fab) | ANC-193-580 | Ancell | Summary Details |
|
| anti-CD44 (human), mAb (BU52) (FITC) | ANC-193-040 | Ancell | Summary Details |
|
| anti-CD44 (human), mAb (BU52) (preservative free) | ANC-193-820 | Ancell | Summary Details |
|
| anti-CD44 (human), mAb (BU52) (R-PE) | ANC-193-050 | Ancell | Summary Details |
|
| anti-CD44 (human), mAb (BU75) | ANC-352-020 | Ancell | Summary Details |
|
| anti-CD44 (human), mAb (BU75) (Biotin) | ANC-352-030 | Ancell | Summary Details |
|
| anti-CD44 (human), mAb (BU75) (FITC) | ANC-352-040 | Ancell | Summary Details |
|
| anti-CD44 (human), mAb (BU75) (preservative free) | ANC-352-820 | Ancell | Summary Details |
|
| anti-CD44 (human), mAb (BU75) (R-PE) | ANC-352-050 | Ancell | Summary Details |
|
| anti-CD45 (human), mAb (C11) | ANC-196-020 | Ancell | Summary Details |
|
| anti-CD45 (human), mAb (C11) (APC) | ANC-196-060 | Ancell | Summary Details |
|
| anti-CD45 (human), mAb (C11) (Biotin) | ANC-196-030 | Ancell | Summary Details |
|
| anti-CD45 (human), mAb (C11) (FITC) | ANC-196-040 | Ancell | Summary Details |
|
| anti-CD45 (human), mAb (C11) (preservative free) | ANC-196-820 | Ancell | Summary Details |
|
| anti-CD45 (human), mAb (C11) (R-PE) | ANC-196-050 | Ancell | Summary Details |
|
| anti-CD45R (human), mAb (351C5) | ANC-195-020 | Ancell | Summary Details |
|
| anti-CD45R (human), mAb (351C5) (Biotin) | ANC-195-030 | Ancell | Summary Details |
|
| anti-CD45R (human), mAb (351C5) (FITC) | ANC-195-040 | Ancell | Summary Details |
|
| anti-CD45R (human), mAb (351C5) (preservative free) | ANC-195-820 | Ancell | Summary Details |
|
| anti-CD45R [B220] (mouse), mAb (RA3-3A1/6.1) | ANC-720-020 | Ancell | Summary Details |
|
| anti-CD45R [B220] (mouse), mAb (RA3-3A1/6.1) (Biotin) | ANC-720-030 | Ancell | Summary Details |
|
| anti-CD45R [B220] (mouse), mAb (RA3-3A1/6.1) (FITC) | ANC-720-040 | Ancell | Summary Details |
|
| anti-CD45R [B220] (mouse), mAb (RA3-3A1/6.1) (preservative free) | ANC-720-820 | Ancell | Summary Details |
|
| anti-CD45RA (human), mAb (158.4D3) | ANC-394-020 | Ancell | Summary Details |
|
| anti-CD45RA (human), mAb (158.4D3) (Biotin) | ANC-394-030 | Ancell | Summary Details |
|
| anti-CD45RA (human), mAb (158.4D3) (FITC) | ANC-394-040 | Ancell | Summary Details |
|
| anti-CD45RA (human), mAb (158.4D3) (preservative free) | ANC-394-820 | Ancell | Summary Details |
|
| anti-CD45RA (human), mAb (158.4D3) (R-PE) | ANC-394-050 | Ancell | Summary Details |
|
| anti-CD45RO (human), mAb (UCHL1) | ANC-194-020 | Ancell | Summary Details |
|
| anti-CD45RO (human), mAb (UCHL1) (Biotin) | ANC-194-030 | Ancell | Summary Details |
|
| anti-CD45RO (human), mAb (UCHL1) (FITC) | ANC-194-040 | Ancell | Summary Details |
|
| anti-CD45RO (human), mAb (UCHL1) (preservative free) | ANC-194-820 | Ancell | Summary Details |
|
| anti-CD45RO (human), mAb (UCHL1) (R-PE) | ANC-194-050 | Ancell | Summary Details |
|
| anti-CD46 (human), mAb (169-1-E4.3) | ANC-197-020 | Ancell | Summary Details |
|
| anti-CD46 (human), mAb (169-1-E4.3) (Biotin) | ANC-197-030 | Ancell | Summary Details |
|
| anti-CD46 (human), mAb (169-1-E4.3) (FITC) | ANC-197-040 | Ancell | Summary Details |
|
| anti-CD46 (human), mAb (169-1-E4.3) (preservative free) | ANC-197-820 | Ancell | Summary Details |
|
| anti-CD46 (human), mAb (169-1-E4.3) (R-PE) | ANC-197-050 | Ancell | Summary Details |
|
| anti-CD47 (human), mAb (ANC2F6) | ANC-198-020 | Ancell | Summary Details |
|
| anti-CD47 (human), mAb (ANC2F6) (Biotin) | ANC-198-030 | Ancell | Summary Details |
|
| anti-CD47 (human), mAb (ANC2F6) (FITC) | ANC-198-040 | Ancell | Summary Details |
|
| anti-CD47 (human), mAb (ANC2F6) (preservative free) | ANC-198-820 | Ancell | Summary Details |
|
| anti-CD47 (human), mAb (ANC2F6) (R-PE) | ANC-198-050 | Ancell | Summary Details |
|
| anti-CD48 (human), mAb (5-4.8) | ANC-199-020 | Ancell | Summary Details |
|
| anti-CD48 (human), mAb (5-4.8) (Biotin) | ANC-199-030 | Ancell | Summary Details |
|
| anti-CD48 (human), mAb (5-4.8) (FITC) | ANC-199-040 | Ancell | Summary Details |
|
| anti-CD48 (human), mAb (5-4.8) (preservative free) | ANC-199-820 | Ancell | Summary Details |
|
| anti-CD48 (human), mAb (5-4.8) (R-PE) | ANC-199-050 | Ancell | Summary Details |
|
| anti-CD49b (human), mAb (HAS6) | ANC-155-020 | Ancell | Summary Details |
|
| anti-CD49b (human), mAb (HAS6) (Biotin) | ANC-155-030 | Ancell | Summary Details |
|
| anti-CD49b (human), mAb (HAS6) (FITC) | ANC-155-040 | Ancell | Summary Details |
|
| anti-CD49b (human), mAb (HAS6) (preservative free) | ANC-155-820 | Ancell | Summary Details |
|
| anti-CD49b (human), mAb (HAS6) (R-PE) | ANC-155-050 | Ancell | Summary Details |
|
| anti-CD49d (human), mAb (BU49) | ANC-200-020 | Ancell | Summary Details |
|
| anti-CD49d (human), mAb (BU49) (Biotin) | ANC-200-030 | Ancell | Summary Details |
|
| anti-CD49d (human), mAb (BU49) (FITC) | ANC-200-040 | Ancell | Summary Details |
|
| anti-CD49d (human), mAb (BU49) (preservative free) | ANC-200-820 | Ancell | Summary Details |
|
| anti-CD49d (human), mAb (BU49) (R-PE) | ANC-200-050 | Ancell | Summary Details |
|
| anti-CD49f (human), mAb (BQ16) | ANC-356-020 | Ancell | Summary Details |
|
| anti-CD49f (human), mAb (BQ16) (Biotin) | ANC-356-030 | Ancell | Summary Details |
|
| anti-CD49f (human), mAb (BQ16) (FITC) | ANC-356-040 | Ancell | Summary Details |
|
| anti-CD49f (human), mAb (BQ16) (preservative free) | ANC-356-820 | Ancell | Summary Details |
|
| anti-CD49f (human), mAb (BQ16) (R-PE) | ANC-356-050 | Ancell | Summary Details |
|
| anti-CD5 (human), mAb (UCHT2) | ANC-150-020 | Ancell | Summary Details |
|
| anti-CD5 (human), mAb (UCHT2) (Biotin) | ANC-150-030 | Ancell | Summary Details |
|
| anti-CD5 (human), mAb (UCHT2) (FITC) | ANC-150-040 | Ancell | Summary Details |
|
| anti-CD5 (human), mAb (UCHT2) (preservative free) | ANC-150-820 | Ancell | Summary Details |
|
| anti-CD5 (human), mAb (UCHT2) (R-PE) | ANC-150-050 | Ancell | Summary Details |
|
| anti-CD50 (human), mAb (186-2G9) | ANC-201-020 | Ancell | Summary Details |
|
| anti-CD50 (human), mAb (186-2G9) (Biotin) | ANC-201-030 | Ancell | Summary Details |
|
| anti-CD50 (human), mAb (186-2G9) (FITC) | ANC-201-040 | Ancell | Summary Details |
|
| anti-CD50 (human), mAb (186-2G9) (preservative free) | ANC-201-820 | Ancell | Summary Details |
|
| anti-CD50 (human), mAb (186-2G9) (R-PE) | ANC-201-050 | Ancell | Summary Details |
|
| anti-CD51 (human), mAb (P2W7) | ANC-202-020 | Ancell | Summary Details |
|
| anti-CD51 (human), mAb (P2W7) (Biotin) | ANC-202-030 | Ancell | Summary Details |
|
| anti-CD51 (human), mAb (P2W7) (FITC) | ANC-202-040 | Ancell | Summary Details |
|
| anti-CD51 (human), mAb (P2W7) (preservative free) | ANC-202-820 | Ancell | Summary Details |
|
| Share |
